Interleukin-4 enhances anti-IgM stimulation of B cells by improving cell viability and by increasing the sensitivity of b cells to the anti-IgM signal
- 1 April 1991
- journal article
- Published by Elsevier in Cellular Immunology
- Vol. 134 (1) , 14-30
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The effects of bacterial lipopolysaccharide, anti‐receptor antibodies and recombinant interferon on mouse B cell cycle progression using 5‐bromo‐2'‐deoxyuridine/hoechst 33258 dye flow cytometryEuropean Journal of Immunology, 1989
- A model of T cell‐target interaction leading to lymphokine releaseImmunology & Cell Biology, 1987
- Human recombinant interleukin 4 induces Fc epsilon receptors (CD23) on normal human B lymphocytes.Journal of Experimental Medicine, 1987
- BLOCKING OF DELIVERY OF THE ANTIGEN-MEDIATED SIGNAL TO THE NUCLEUS OF T CELLS BY CYCLOSPORINSTransplantation, 1987
- B-Cell Stimulatory Factor-1/Interleukin 4Annual Review of Immunology, 1987
- Antigen-specific interaction between T and B cellsNature, 1985
- Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.Journal of Experimental Medicine, 1978
- Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response.Journal of Experimental Medicine, 1978
- Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulinNature, 1975
- THE REQUIREMENT OF MORE THAN ONE ANTIGENIC DETERMINANT FOR IMMUNOGENICITYJournal of Experimental Medicine, 1969